Seeking Alpha

Cerus Corporation (CERS)

  • TradeIt Mike | Send Message 5 Mar

    SELL $CERS 4.44 not acting well.
      • TradeIt Mike | Send Message 3 Mar

        BUY $CERS 4.44
          • ARK Investment Management | Send Message 28 Feb

            Cerus Squeezes Healthy Blood From A Stone $CERS
              • sundara99 | Send Message 26 Feb

                Investing Alongside Billionaires, It's Paying Off Already $CERS, $GURU, $BNFT
                  • UNEMON1 | Send Message 6 Jan

                    CERUS CORP: Up For The Wrong Reasons, Now Time For The 35% Drop $CERS
                    Reply (1)
                    • BiotechX | Send Message 29 Jan
                      : But now with almost $110M cash on hand and the INTERCEPT Red Blood Cells Trials in US /EU met primary endpoint in PII /PIII-looks good to me
                      • BiotechX | Send Message 5 Jan

                        Everyday more good news for $CERS - "EU Phase 3 Study Of INTERCEPT Red Blood Cells Meets Primary Endpoint".
                          • LaboMedic | Send Message 23 Dec 2014

                            $CERS MLV Maintains Buy On Cerus Following Phase II Results Of INTERCEPT Red Blood Cells
                              • LaboMedic | Send Message 21 Dec 2014

                                Analyst Highlights - Week 51 - Healthcare (Part II) $OCAT $CERS $TGTX $CTIC $MACK
                                  • Value Insight | Send Message 19 Dec 2014

                                    Cerus Soaring On FDA Approval Of Intercept $CERS
                                      • LaboMedic | Send Message 19 Dec 2014

                                        $CERS UPDATE: MLV Reiterates Bullish Stance On Cerus Following Two FDA Approvals In A Week
                                          Visit Seeking Alpha's
                                          CERS vs. ETF Alternatives
                                          Company Description
                                          Cerus Corp is a biomedical products company. It is engaged indeveloping andcommercializing the INTERCEPT Blood System to enhance blood safety.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States